ArticleFrontiers in pharmacology2026

Immune heterogeneity-driven therapeutic responses to platelet-rich plasma and TRPV1 antagonism in osteoarthritis.

Pengmin Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.